An ad hoc committee of Drug Forum members will plan and host a public workshop which examine the state of the science of drug regulation and consider approaches for enhancing the scientific basis of regulatory decision making. Individuals from the federal government, pharmaceutical industry, academia, industry, and patient groups will be invited to make presentations and discuss different perspectives on the strengths and weaknesses of the current regulatory science framework. They will also consider strategies for improving regulatory science, which may include: fostering a scientific discipline of regulatory science; promoting closer collaboration between of regulatory and academic researchers; and developing a multi-sectoral infrastructure for regulatory science, which may include regulatory science centers of excellence, innovative federal grant-making mechanisms, and professional development strategies. A summary of the workshop will be prepared in accordance with institutional policy and procedures.